window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 8, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Pharmaceuticals and therapeutics

  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Polaryx advances Phase 2 trial of PLX-200 in four rare diseases

    Polaryx Therapeutics is preparing to start its Phase 2 SOTERIA [...]

    August 26, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Lumen Bioscience gets up to $7M to advance LMN-1001 into Phase 1

    Lumen Bioscience has received up to $7m in US government [...]

    August 25, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Genespire starts international MMA study to support GENE202 development

    Genespire has started enrolling children with severe methylmalonic acidemia in [...]

    August 25, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    FDA grants Fast Track designation to Erasca pancreatic cancer drug

    The FDA has granted Fast Track designation to Erasca’s investigational [...]

    August 24, 2026
  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Therapeutic Areas

    FDA grants De Novo authorisation to Avulux migraine light-sensitivity lens

    The FDA has granted De Novo marketing authorisation to Avulux, [...]

    August 24, 2026
  • Clinical & Regulatory,Medical devices,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Robotic gastrectomy shows benefits over laparoscopic surgery in gastric cancer

    Large Japanese study finds robotic surgery reduces blood loss, conversions [...]

    August 24, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development

    Leicester clinic offers Galleri blood test following NHS cancer trial

    A Leicester private GP clinic has begun offering Galleri, a [...]

    August 24, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development

    Poolbeg Pharma trial targets cytokine release syndrome in multiple myeloma

    Poolbeg Pharma’s Phase 2a TOPICAL trial is investigating whether POLB [...]

    August 21, 2026
  • Drug Discovery & Development,Pharmaceuticals and therapeutics

    FairJourney Bio builds switch to activate IL-12 in tumours

    FairJourney Bio has helped engineer a reversible antibody switch designed [...]

    August 20, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Aurora Cannabis acquires UK medical cannabis importer and pharmacy

    Aurora Cannabis has acquired a UK licensed medical cannabis importer [...]

    August 20, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • How AI is reshaping clinical trials: Saama on the next phase of regulated AI
    Categories: Clinical & Regulatory, Digital & Data, Drug Discovery & Development, Research & Development
  • MRI study suggests some prostate cancer biopsies could eventually be avoided
    Categories: Clinical & Regulatory, Medical devices, Research & Development, Therapeutic Areas
  • START and Allegheny Health Network to expand access to early-phase cancer trials
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top